Christopher M. Clark

Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

Use of Florbetapir-PET for Imaging β-Amyloid Pathology

Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study

Validity and Reliability of the Alzheimerʼs Disease Cooperative Study-Clinical Global Impression of Change

FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease

Increase of Brain Oxidative Stress in Mild Cognitive Impairment

YKL-40: A Novel Prognostic Fluid Biomarker for Preclinical Alzheimer's Disease

Consortium to Establish a Registry for Alzheimer's Disease (CERAD): The first twenty years

Frontotemporal dementia: Clinicopathological correlations

Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases

Concomitant TAR-DNA-Binding Protein 43 Pathology Is Present in Alzheimer Disease and Corticobasal Degeneration but Not in Other Tauopathies